1. Home
  2. STRA vs SUPN Comparison

STRA vs SUPN Comparison

Compare STRA & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRA
  • SUPN
  • Stock Information
  • Founded
  • STRA 2017
  • SUPN 2005
  • Country
  • STRA United States
  • SUPN United States
  • Employees
  • STRA N/A
  • SUPN N/A
  • Industry
  • STRA Other Consumer Services
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRA Real Estate
  • SUPN Health Care
  • Exchange
  • STRA Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • STRA 2.0B
  • SUPN 1.7B
  • IPO Year
  • STRA 1996
  • SUPN 2012
  • Fundamental
  • Price
  • STRA $89.26
  • SUPN $31.70
  • Analyst Decision
  • STRA
  • SUPN Hold
  • Analyst Count
  • STRA 0
  • SUPN 2
  • Target Price
  • STRA N/A
  • SUPN $36.00
  • AVG Volume (30 Days)
  • STRA 227.0K
  • SUPN 420.5K
  • Earning Date
  • STRA 04-24-2025
  • SUPN 05-06-2025
  • Dividend Yield
  • STRA 2.72%
  • SUPN N/A
  • EPS Growth
  • STRA 11.28
  • SUPN N/A
  • EPS
  • STRA 4.68
  • SUPN 1.11
  • Revenue
  • STRA $1,233,270,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • STRA $6.07
  • SUPN N/A
  • Revenue Next Year
  • STRA $5.18
  • SUPN $9.14
  • P/E Ratio
  • STRA $18.85
  • SUPN $28.49
  • Revenue Growth
  • STRA 5.72
  • SUPN 11.82
  • 52 Week Low
  • STRA $74.28
  • SUPN $25.53
  • 52 Week High
  • STRA $123.41
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • STRA 68.16
  • SUPN 47.88
  • Support Level
  • STRA $87.76
  • SUPN $29.16
  • Resistance Level
  • STRA $89.94
  • SUPN $33.28
  • Average True Range (ATR)
  • STRA 2.58
  • SUPN 1.19
  • MACD
  • STRA 1.19
  • SUPN 0.02
  • Stochastic Oscillator
  • STRA 94.68
  • SUPN 61.65

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: